LSZ

What is LSZ?

LSZ, also known as lysergic acid 2,4-dimethylazetidide or LA-SS-Az, is a synthetic psychedelic lysergamide related to LSD. Its amide group is incorporated into a 2,4-dimethylazetidine ring, rather than the diethylamide group found in LSD. The compound was first encountered on the new psychoactive substance market around 2013, usually in blotter or powder form.

Chemistry and analytical identification

The name LSZ refers to the two methyl substituents on the azetidine ring. The configuration of these groups matters: the material most often characterized in forensic studies is the (2′S,4′S) stereoisomer. Other stereoisomers are chemically possible, but should not be assumed to have the same pharmacological properties.

In their analytical and behavioural study of LSZ, Brandt and colleagues examined powdered LSZ tartrate and blotter material using nuclear magnetic resonance spectroscopy, gas chromatography–mass spectrometry, high-resolution electrospray mass spectrometry, HPLC with diode-array detection and GC solid-state infrared analysis. The work established a detailed reference profile for forensic identification and included a mouse head-twitch response experiment to assess hallucinogen-like activity. The same investigation also provided the mouse behavioural data discussed below.

Pharmacology

LSZ produced a dose-dependent head-twitch response in mice, a behavioural model associated with 5-HT2A receptor activation. Its estimated ED50 was 114.2 nmol/kg, compared with 132.8 nmol/kg for LSD in the reference experiment. On that measure, LSZ was approximately equipotent to LSD in mice. The researchers also found that the maximum response was lower than that produced by AL-LAD, illustrating that potency and maximum behavioural effect are not the same property.

These findings support LSD-like activity in the animal model, but they do not establish that LSZ is equally potent in humans. Head-twitch response is a useful preclinical assay, not a direct measurement of subjective intensity. The study’s authors explicitly cautioned against translating the numerical comparison directly to people.

Subjective effects

Human descriptions of LSZ come mainly from online reports. Accounts collected by PsychonautWiki generally compare it with LSD, describing visual geometry, changes in colour and depth perception, stimulation and altered thought. Some reports describe a more stimulating or physically uncomfortable experience, while others emphasize a relatively clear mental state. These descriptions are inconsistent and have not been tested in a controlled human study.

Physical and visual effectsCognitive and emotional effects
  • Visual enhancement: colours and fine detail may appear more pronounced.
  • Geometry: repeating patterns and more complex visual structures are described.
  • Movement distortions: surfaces may seem to drift or breathe, with tracers and afterimages also reported.
  • Stimulation: increased energy and wakefulness are described in some accounts.
  • Physical discomfort: nausea, muscle tension, jaw clenching and restlessness may occur.
  • Introspection: reports describe changes in the flow of thought and increased attention to internal associations.
  • Time distortion: the passage of time may seem altered.
  • Emotional changes: euphoria, laughter and heightened appreciation of music appear in some accounts.
  • Anxiety and confusion: difficult experiences may involve unease, repetitive thoughts or sensory overload.

The reported similarity to LSD fits the mouse behavioural findings, although the two substances may differ in their subjective effects. The available human reports are self-selected and do not provide reliable information about pharmacokinetics, duration or the frequency of adverse effects.

Forensic and clinical evidence

LSZ has been analytically confirmed in blotter material, but there is little published clinical information beyond its chemical characterization and preclinical activity. The available literature does not define its metabolism in humans or establish a dose–response relationship. As with other lysergamides, the presence of a familiar blotter design or a product label cannot confirm the identity or purity of the material.

LSZ Products

LSZ liquid

LSZ liquid

Price range: $410.00 through $2,882.00
Select options
LSZ pellets

LSZ pellets

Price range: $473.00 through $2,930.00
Select options
LSZ blotters

LSZ blotters

Price range: $420.00 through $2,100.00
Select options

Scientific Data

Identity and Structure

Chemical NameLSZ
Catalog Entity TypeCompound
FormulaC21H25N3O
Molar Mass335.451 g·mol−1
CAS470666-31-0
470666-32-1
CAS Numbers and Substance Formsfreebase: 470666-31-0
tartrate salt: 470666-32-1
SynonymsLysergic acid 2,4-dimethylazetidine; Lysergic acid 2S,4S-dimethylazetidine; LSZ; LA-Azetidide; LSD-Azetidide; LA-SS-Az; SS-LSZ; (S,S)-LSZ; Diazedine; λ; Lambda
IUPAC Name[(6aR,9R)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-yl]-[(2S,4S)-2,4-dimethylazetidin-1-yl]methanone
InChIInChI=1S/C21H25N3O/c1-12-7-13(2)24(12)21(25)15-8-17-16-5-4-6-18-20(16)14(10-22-18)9-19(17)23(3)11-15/h4-6,8,10,12-13,15,19,22H,7,9,11H2,1-3H3/t12-,13-,15+,19+/m0/s1
InChIKeyDUKNIHFTDAXJON-CTQRGLTFSA-N
SMILESfreebase: C[C@H]1C[C@@H](N1C(=O)[C@H]2CN([C@@H]3CC4=CNC5=CC=CC(=C45)C3=C2)C)C

Chemical Identifiers

PubChem CID71301249
ChemSpider ID30773535
DrugBank IDDB15196
UNII8SWJ525W4R
CompTox DTXSIDDTXSID201026958

Clinical Data

Drug ClassNon-selective serotonin receptor agonist; Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen
Routes of AdministrationOral

Pharmacokinetics

Duration of Action3–11 hours (median 8 hours)

Legal Status

Legal Status (Wikipedia Source Text)DE: NpSG (Industrial and scientific use only)
UK: Class A
Illegal in Denmark, France, Sweden, and Switzerland

Sources and Attribution

Wikipedia Source URLhttps://en.wikipedia.org/?curid=19909799